Capital World Investors Bausch Health Companies Inc. Transaction History

Capital World Investors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $4.32 Million - $5.56 Million	-200,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $17.3 Million - $21.8 Million	-751,447 Reduced 78.98%	200,000 $5.52 Million
Q4 2020 Feb 12, 2021	BUY	$15.31 - $21.12 $8,037 - $11,088	525 Added 0.06%	951,447 $19.8 Million
Q4 2019 Feb 18, 2020	BUY	$18.89 - $31.89 $14.2 Million - $23.9 Million	750,922 Added 375.46%	950,922 $28.5 Million
Q3 2018 Nov 14, 2018	SELL	$20.64 - $25.67 $18.6 Million - $23.1 Million	-900,000 Reduced 81.82%	200,000 $5.13 Million
Q2 2018 Aug 14, 2018	BUY	$15.07 - $26.86 $16.6 Million - $29.5 Million	1,100,000 New	1,100,000 $25.6 Million

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.82B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.